[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-350644-105":59,"doc-detail-350644-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","expanding-hpv-prevention-across-the-life-course-evidence-on-vaccine-effectiveness-in-adults","Expanding HPV prevention across the life course - evidence on vaccine effectiveness in adults","","Narrative review synthesizing and critically discussing recent evidence on HPV vaccination effectiveness among adults to support integration into adult immunization programmes. The review evaluates vaccine effectiveness across adult populations with outcomes including HPV infection and viral dynamics, precancerous cervical lesions (HSIL/CIN), prevention of post-treatment recurrence, HPV-related cancers, and anogenital warts. Findings indicate reductions in HPV infection and viral persistence, while effect estimates vary widely for high-grade cervical lesions (CIN2+), framing relevance for life-course vaccination.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/expanding-hpv-prevention-across-the-life-course-evidence-on-vaccine-effectiveness-in-adults/350644/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/expanding-hpv-prevention-across-the-life-course-evidence-on-vaccine-effectiveness-in-adults/350644.png","ImageObject",300,407,{"name":92,"@type":93},"awa","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-28","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What does the review focus on regarding HPV vaccination?","Question",{"text":112,"@type":113},"It characterizes HPV vaccine effectiveness among adults aged 18–45 years and discusses how evidence can inform integration into adult immunization programmes.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which outcome categories are used to evaluate vaccine effectiveness?",{"text":117,"@type":113},"Vaccine effectiveness is assessed for HPV infection and viral dynamics, precancerous cervical lesions (HSIL/CIN), prevention of post-treatment recurrence, HPV-related cancers, and anogenital warts.",{"name":119,"@type":110,"acceptedAnswer":120},"What patterns do the review findings show across studies?",{"text":121,"@type":113},"Some associations link vaccination with reduced HPV infection and viral persistence, but effect estimates vary widely for high-grade cervical lesions (CIN2+).","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},350644,1790146569,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":44,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},3985747858093,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","TYPE Review  \nPUBLISHED 24 July 2026  \nDOI 10.3389/fpubh.2026.1894760  \nOPEN ACCESS  \nEDITED BY  \nDaniel Diaz,  \nNational Autonomous University of Mexico, Mexico  \nREVIEWED BY  \nHamed Aghazadeh,  \nTabriz University of Medical Sciences, Iran  \nBekana K. Tadese,  \nMerck & Co Inc Upper Gwynedd, United States  \n*CORRESPONDENCE  \nMarta Lomazzi  \n [marta.lomazzi@wfpha.org](marta.lomazzi@wfpha.org)  \n†These authors have contributed equally to this work  \nRECEIVED 29 May 2026  \nREVISED 02 July 2026  \nACCEPTED 03 July 2026  \nPUBLISHED 24 July 2026  \nCITATION  \nBejarano-Hernández L, Chan A, Gosalia M, Moore M, Borisch B, Bedi R and Lomazzi M (2026)  \nExpanding HPV prevention across the life course: evidence on vaccine effectiveness in adults.  \nFront. Public Health 14:1894760 .  \ndoi: 10.3389/fpubh.2026.1894760  \nCOPYRIGHT  \n© 2026 Bejarano-Hernández, Chan, Gosalia, Moore, Borisch, Bedi and Lomazzi. This is an open-access article distributed under the terms of the  \nCreative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nExpanding HPV prevention across the life course: evidence on vaccine effectiveness in adults  \nLorena Bejarano-Hernández 1†, Angela Chan 1†, Meera Gosalia 1 , 2, Michael Moore 1 , 3, Bettina Borisch 1, Raman Bedi 1 ,4 and  \nMarta Lomazzi 1 , 5*  \n1World Federation of Public Health Associations (WFPHA), Institute of Global Health, University of Geneva, Campus Biotech – G6, Geneva, Switzerland, 2University College London Medical School, London, United Kingdom, 3Health Research Institute, University of Canberra, Bruce, ACT, Australia, 4Dental Institute, Kings College London, London, United Kingdom, 5Institute of Global Health, University of Geneva, Campus Biotech – G6, Geneva, Switzerland  \nDespite Human Papillomavirus (HPV) remaining a major global public health concern and affecting all age groups and genders, most HPV vaccination programmes mainly target female adolescents. This narrative review synthesizesand critically discusses recent evidence on the effectiveness of HPV vaccination among adults to inform its integration into adult immunization programmes. A substantial body of recent literature has examined the effectiveness of HPV vaccination in adult populations. Across the literature, vaccine effectiveness has been evaluated in relation to (1) HPV infection and viral dynamics,(2) precancerous cervical lesions (HSIL/CIN),(3) prevention of post-treatment recurrence,(4) HPV-related cancers, and (5) anogenital warts. Some associations were found between HPV vaccination and reduced HPV infection and viral persistence, whilst effect estimates varied widely across studies for high-grade cervical lesions (CIN2+) . This review aims to characterize the effectiveness of the HPV vaccination amongst adults (18–45 years) in preventing human papillomavirus infections and HPV related disease outcomes. By synthesizing and evaluating recent evidence on HPV vaccine efficacy, we aim to assess its relevance in expanding HPV vaccination within life-course immunization programs.  \nKEYWORDS  \nadults, cervical cancer, HPV immunization, HPV vaccination, HPV vaccine, HPV-related cancers, human papillomavirus (HPV), vaccine effectiveness  \n1 Introduction  \nHuman Papillomavirus (HPV) remains a major global public health concern due to its association with a range of cancers, including cervical, anal, oropharyngeal, vaginal, vulvar, and penile cancers ( 1–3) . It is estimated that up to 80% of sexually active individuals will acquire the HPV infection at some point in their lives (4). Among HPV-related cancers, cervical cancer remains the most impactful in terms of mortality and health inequities, ranking asthe fourth ","cbCaiql8UOfRY12s","https://ap.wps.com/l/cbCaiql8UOfRY12s","pdf",267168,"English","# Introduction\n## Adult HPV vaccination evidence and coverage gap\n## Rationale for a life-course immunization approach","[{\"question\":\"What does the review focus on regarding HPV vaccination?\",\"answer\":\"It characterizes HPV vaccine effectiveness among adults aged 18–45 years and discusses how evidence can inform integration into adult immunization programmes.\"},{\"question\":\"Which outcome categories are used to evaluate vaccine effectiveness?\",\"answer\":\"Vaccine effectiveness is assessed for HPV infection and viral dynamics, precancerous cervical lesions (HSIL/CIN), prevention of post-treatment recurrence, HPV-related cancers, and anogenital warts.\"},{\"question\":\"What patterns do the review findings show across studies?\",\"answer\":\"Some associations link vaccination with reduced HPV infection and viral persistence, but effect estimates vary widely for high-grade cervical lesions (CIN2+).\"}]","Expanding HPV prevention across the life course - evidence on vaccine effectiveness in adults | PDF",1790090359,23,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/769eab123bbda638d83724ceb6b17aa0.webp",983,1390,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f5a507803abc1ac5770c33f7123d6c6a.webp",982,1388,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c53e6f6f07634a0a6bd76848d4c00e1b.webp",981,1387,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/77da40a182774f6259602c004a95e141.webp",980,1385]